Santarus Inc. (SNTS)


Santarus is evaluating the details of the Paragraph IV Notice certification from Par and continues to have full confidence in the intellectual property protecting ZEGERID.

Contact Information

10590 West Ocean Air Drive
Suite 200
San Diego, CA 92130

tel: 858-314-5700
fax: 858-314-5701


Investor Relations



Exchange: NASDAQ
Industry: Drug Manufacturers - Other
Market Cap: $132.9M

The information provided here has been obtained from publicly available sources as well as directly from issuers in some cases. Please see our Disclaimer and Terms of Service for more information.